Beneficial anti-inflammatory effect of paeonol self-microemulsion-loaded colon-specific capsules on experimental ulcerative colitis rats

References

• Yang Y, He J, Suo Y, et al. Tauroursodeoxycholate improves 2,4,6-trinitrobenzenesulfonic acid-induced experimental acute ulcerative colitis in mice. Int Immunopharmacol. 2016;36:271–276.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhai W, Jiang Q, et al. Curcumin–piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy. Int J Pharm. 2015;490:22–31.
   PubMed Web of Science ®Google Scholar
• Agis ER, Savas B, Melli M. Impact of colonic mucosal lipoxin A4 synthesis capacity on healing in rats with dextran sodium sulfate-induced colitis. Prostaglandins Other Lipid Mediat. 2015;121:63–69.
   PubMed Web of Science ®Google Scholar
• Trivedi PP, Jena GB. Ulcerative colitis-induced hepatic damage in mice: studies on inflammation, fibrosis, oxidative DNA damage and GST-P expression. Chem Biol Interact. 2013;201:19–30.
   PubMed Web of Science ®Google Scholar
• Wang YH, Ge B, Yang XL, et al. Proanthocyanidins from grape seeds modulates the nuclear factor-kappa B signal transduction pathways in rats with TNBS-induced recurrent ulcerative colitis. Int Immunopharmacol. 2011;11:1620–1627.
   PubMed Web of Science ®Google Scholar
• Samsami-Kor M, Daryani NE, Asl PR, et al. Anti-inflammatory effects of resveratrol in patients with ulcerative colitis: a randomized, double-blind, placebo-controlled pilot study. Arch Med Res. 2015;46:280–285.
   PubMed Web of Science ®Google Scholar
• Vong LB, Mo J, Abrahamsson B, et al. Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose-response efficacy. J Control Release: Off J Control Release Soc. 2015;210:19–25.
   PubMed Web of Science ®Google Scholar
• Yun CS, Choi YG, Jeong MY, et al. Moutan cortex radicis inhibits inflammatory changes of gene expression in lipopolysaccharide-stimulated gingival fibroblasts. J Nat Med. 2013;67:576–589.
   PubMed Web of Science ®Google Scholar
• Jamal J, Mustafa MR, Wong PF. Paeonol protects against premature senescence in endothelial cells by modulating Sirtuin 1 pathway. J Ethnopharmacol. 2014;154:428–436.
   PubMed Web of Science ®Google Scholar
• Gong X, Yang Y, Huang L, et al. Antioxidation, anti-inflammation and anti-apoptosis by paeonol in LPS/d-GalN-induced acute liver failure in mice. Int Immunopharmacol. 2017;46:124–132.
   PubMed Web of Science ®Google Scholar
• Fu PK, Yang CY, Huang SC, et al. Evaluation of LPS-induced acute lung injury attenuation in rats by aminothiazole-paeonol derivatives. Molecules. 2017;22:1605.
   Web of Science ®Google Scholar
• Meng Y, Wang M, Xie X, et al. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells. Int J Mol Med. 2017;39:1101–1110.
   PubMed Web of Science ®Google Scholar
• Zhang L, Tao L, Shi T, et al. Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways. IUBMB Life. 2015;67:778–788.
   PubMed Web of Science ®Google Scholar
• Li M, Tan SY, Wang XF. Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE2 synthesis and COX-2 expression. Oncol Rep. 2014;32:2845–2853.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang S, Feng L, et al. Hypoglycemic and antioxidant activities of paeonol and its beneficial effect on diabetic encephalopathy in streptozotocin-induced diabetic rats. J Med Food. 2013;16:577–586.
   PubMed Web of Science ®Google Scholar
• Ye M, Yi Y, Wu S, et al. Role of paeonol in an astrocyte model of Parkinson’s disease. Med Sci Monit. 2017;23:4740–4748.
   PubMed Web of Science ®Google Scholar
• Shi X, Chen YH, Liu H, et al. Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson’s disease in mice. Mol Med Rep. 2016;14:2397–2404.
   PubMed Web of Science ®Google Scholar
• Lyu ZK, Li CL, Jin Y, et al. Paeonol exerts potential activities to inhibit the growth, migration and invasion of human gastric cancer BGC823 cells via downregulating MMP2 and MMP9. Mol Med Rep. 2017;16:7513–7519.
   PubMed Web of Science ®Google Scholar
• Zhou HM, Sun QX, Cheng Y. Paeonol enhances the sensitivity of human ovarian cancer cells to radiotherapy-induced apoptosis due to downregulation of the phosphatidylinositol-3-kinase/Akt/phosphatase and tensin homolog pathway and inhibition of vascular endothelial growth factor. Exp Ther Med. 2017;14:3213–3220.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhu JY, Lei ZM, et al. Anti-proliferative effects of paeonol on human prostate cancer cell lines DU145 and PC-3. J Physiol Biochem. 2017;73:157–165.
   PubMed Web of Science ®Google Scholar
• Zhai KF, Duan H, Luo L, et al. Protective effects of paeonol on inflammatory response in IL-1beta-induced human fibroblast-like synoviocytes and rheumatoid arthritis progression via modulating NF-kappaB pathway. Inflammopharmacology 2017;25:523–532.
   Web of Science ®Google Scholar
• Liu N, Feng X, Wang W, et al. Paeonol protects against TNF-alpha-induced proliferation and cytokine release of rheumatoid arthritis fibroblast-like synoviocytes by upregulating FOXO3 through inhibition of miR-155 expression. Inflamm Res. 2017;66:603–610.
   PubMed Web of Science ®Google Scholar
• Lou Y, Wang C, Tang Q, et al. Paeonol inhibits IL-1beta-induced inflammation via PI3K/Akt/NF-kappaB pathways: in vivo and vitro studies. Inflammation. 2017;40:1698–1706.
   PubMed Web of Science ®Google Scholar
• Choy KW, Lau YS, Murugan D, et al. Chronic treatment with paeonol improves endothelial function in mice through inhibition of endoplasmic reticulum stress-mediated oxidative stress. PLoS One. 2017;12:e0178365.
   PubMed Web of Science ®Google Scholar
• Ma L, Chuang CC, Weng W, et al. Paeonol protects rat heart by improving regional blood perfusion during no-reflow. Front Physiol. 2016;7:298.
   PubMed Web of Science ®Google Scholar
• Zong SY, Pu YQ, Xu BL, et al. Study on the physicochemical properties and anti-inflammatory effects of paeonol in rats with TNBS-induced ulcerative colitis. Int Immunopharmacol. 2017;42:32–38.
   PubMed Web of Science ®Google Scholar
• Liu MH, Lin AH, Ko HK, et al. Prevention of bleomycin-induced pulmonary inflammation and fibrosis in mice by paeonol. Front Physiol. 2017;8:193.
   PubMed Web of Science ®Google Scholar
• Xue P, Wang Y, Zeng F, et al. Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase. Oncotarget. 2017;8:27093–27104.
   PubMed Web of Science ®Google Scholar
• Wu J, Xu L, Sun C, et al. Paeonol alleviates epirubicin-induced renal injury in mice by regulating Nrf2 and NF-kappaB pathways. Eur J Pharmacol. 2017;795:84–93.
   PubMed Web of Science ®Google Scholar
• Fan HY, Qi D, Yu C, et al. Paeonol protects endotoxin-induced acute kidney injury: potential mechanism of inhibiting TLR4-NF-kappaB signal pathway. Oncotarget. 2016;7:39497–39510.
   PubMed Web of Science ®Google Scholar
• He LX, Tong X, Zeng J, et al. Paeonol suppresses neuroinflammatory responses in LPS-activated microglia cells. Inflammation. 2016;39:1904–1917.
   PubMed Web of Science ®Google Scholar
• Lin C, Lin HY, Chen JH, et al. Effects of paeonol on anti-neuroinflammatory responses in microglial cells. Int J Mol Sci. 2015;16:8844–8860.
   PubMed Web of Science ®Google Scholar
• Chang CY, Fu E, Chiang CY, et al. Effect of paeonol on tissue destruction in experimental periodontitis of rats. Am J Chin Med. 2014;42:361–374.
   PubMed Web of Science ®Google Scholar
• Ishiguro K, Ando T, Maeda O, et al. Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation. Toxicol Appl Pharmacol. 2006;217:35–42.
   PubMed Web of Science ®Google Scholar
• Jin X, Wang J, Xia ZM, et al. Anti-inflammatory and anti-oxidative activities of paeonol and its metabolites through blocking MAPK/ERK/p38 signaling pathway. Inflammation. 2016;39:434–446.
   PubMed Web of Science ®Google Scholar
• Li M, Tan SY, Zhang J, et al. Effects of paeonol on intracellular calcium concentration and expression of RUNX3 in LoVo human colon cancer cells. Mol Med Rep. 2013;7:1425–1430.
   PubMed Web of Science ®Google Scholar
• Harada M, Yamashita A. [Pharmacological studies on the root bark of paeonia moutan. I. Central effects of paeonol]. Yakugaku Zasshi. 1969;89:1205–1211.
   PubMed Web of Science ®Google Scholar
• Luo JY, Zhong Y, Cao JC, et al. Efficacy of oral colon-specific delivery capsule of low-molecular-weight heparin on ulcerative colitis. Biomed Pharmacother. 2011;65:111–117.
   PubMed Web of Science ®Google Scholar
• Yehia SA, Elshafeey AH, Elsayed I. Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation. Drug Deliv. 2011;18:620–630.
   PubMed Web of Science ®Google Scholar
• Chen C, Jia F, Hou Z, et al. Delivery of paeonol by nanoparticles enhances its in vitro and in vivo antitumor effects. Int J Nanomed. 2017;12:6605–6616.
   PubMed Web of Science ®Google Scholar
• Chen ZX, Li B, Liu T, et al. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers. Eur J Pharm Sci. 2017;99:240–245.
   PubMed Web of Science ®Google Scholar
• Yao J, Zeng D, Zhang Y, et al. Effect of solvents on forming poly(butyl-2-cyanoacrylate) encapsulated paeonol nanocapsules. J Biomater Sci Polym Ed. 2017;28:240–256.
   PubMed Web of Science ®Google Scholar
• Yao J, Zhang Y, Hu Q, et al. Optimization of paeonol-loaded poly(butyl-2-cyanoacrylate) nanocapsules by central composite design with response surface methodology together with the antibacterial properties. Eur J Pharm Sci. 2017;101:189–199.
   PubMed Web of Science ®Google Scholar
• Li SS, Li GF, Liu L, et al. Optimization of paeonol-loaded microparticle formulation by response surface methodology. J Microencapsul. 2015;32:677–686.
   PubMed Web of Science ®Google Scholar
• Li SS, Li GF, Liu L, et al. Evaluation of paeonol skin-target delivery from its microsponge formulation: in vitro skin permeation and in vivo microdialysis. PLoS One. 2013;8:e79881.
   PubMed Web of Science ®Google Scholar
• Lin C, Miao Y, Qian M, et al. Enantioselective metabolism of flufiprole in rat and human liver microsomes. J Agric Food Chem. 2016;64:2371–2376.
   PubMed Web of Science ®Google Scholar
• Hu T, Zhou X, Wang L, et al. Effects of tanshinones from Salvia miltiorrhiza on CYP2C19 activity in human liver microsomes: enzyme kinetic and molecular docking studies. Chem Biol Interact. 2015;230:1–8.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xie G, Liu Q, et al. Pharmacokinetics, tissue distribution, and plasma protein binding study of chicoric acid by HPLC-MS/MS. J Chromatogr B: Analyt Technol Biomed Life Sci. 2016;1031:139–145.
   PubMed Web of Science ®Google Scholar
• Waters NJ, Jones R, Williams G, et al. Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. J Pharm Sci. 2008;97:4586–4595.
   PubMed Web of Science ®Google Scholar
• Wang B, Pu Y, Xu B, et al. Self-microemulsifying drug delivery system improved oral bioavailability of 20(S)-protopanaxadiol: from preparation to evaluation. Chem Pharm Bull. 2015;63:688–693.
   PubMed Web of Science ®Google Scholar
• Laxmi M, Bhardwaj A, Mehta S, et al. Development and characterization of nanoemulsion as carrier for the enhancement of bioavailability of artemether. Artif Cells Nanomed Biotechnol. 2015;43:334–344.
   PubMed Web of Science ®Google Scholar
• Li F, Song S, Guo Y, et al. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam. Drug Deliv. 2015;22:487–498.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhang YH, Sheng YX, et al. LC-MS determination and pharmacokinetic studies of paeonol in rat plasma after administration of different compatibility of Su-Xiao-Xin-Tong prescriptions. Biomed Chromatogr. 2008;22:527–534.
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhou H, Wong YF, et al. Study on the pharmacokinetics and metabolism of paeonol in rats treated with pure paeonol and an herbal preparation containing paeonol by using HPLC-DAD-MS method. J Pharm Biomed Anal. 2008;46:748–756.
   PubMed Web of Science ®Google Scholar
• Bhandari S, Bhandari V, Sood J, et al. Improved pharmacokinetic and pharmacodynamic attributes of artemether-lumefantrine-loaded solid SMEDDS for oral administration. J Pharm Pharmacol. 2017;69:1437–1446.
   PubMed Web of Science ®Google Scholar
• Yeom DW, Son HY, Kim JH, et al. Development of a solidified self-microemulsifying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability. Int J Pharm. 2016;506:302–311.
   PubMed Web of Science ®Google Scholar
• Baheti A, Srivastava S, Sahoo D, et al. Development and pharmacokinetic evaluation of industrially viable Self-microemulsifying Drug Delivery Systems (SMEDDS) for terbinafine. Curr Drug Deliv. 2016;13:65–75.
   Web of Science ®Google Scholar
• Mekjaruskul C, Yang YT, Leed MG, et al. Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin. Int J Pharm. 2013;445:1–11.
   PubMed Web of Science ®Google Scholar
• Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995;12:1561–1572.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu W, Yang C, et al. A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting. Int J Nanomed. 2012;7:151–162.
   PubMed Web of Science ®Google Scholar
• Zhou J, Tan L, Xie J, et al. Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice. Drug Deliv. 2017;24:1667–1679.
   PubMed Web of Science ®Google Scholar
• Li Y, Ma H, Wan Y, et al. Volatile organic compounds emissions from luculia pinceana flower and its changes at different stages of flower development. Molecules. 2016;21:531.
   PubMed Web of Science ®Google Scholar
• Xiumin LI, Man GE, Minzi LU, et al. The in vitro and in vivo evaluation of fenofibrate with a self- microemulsifying formulation. Curr Drug Deliv. 2015;12:308–313.
   PubMed Web of Science ®Google Scholar
• Duc Hanh N, Mitrevej A, Sathirakul K, et al. Development of phyllanthin-loaded self-microemulsifying drug delivery system for oral bioavailability enhancement. Drug Dev Ind Pharm. 2015;41:207–217.
   PubMed Web of Science ®Google Scholar
• Taha E, Ghorab D, Zaghloul AA. Bioavailability assessment of vitamin A self-nanoemulsified drug delivery systems in rats: a comparative study. Med Princ Pract. 2007;16:355–359.
   PubMed Web of Science ®Google Scholar
• Patel MM. Formulation and development of di-dependent microparticulate system for colon-specific drug delivery. Drug Deliv Transl Res. 2017;7:312–324.
   PubMed Web of Science ®Google Scholar
• Singh S, Kotla NG, Tomar S, et al. A nanomedicine-promising approach to provide an appropriate colon-targeted drug delivery system for 5-fluorouracil. Int J Nanomed. 2015;10:7175–7182.
   PubMed Web of Science ®Google Scholar
• Wachsmann P, Moulari B, Beduneau A, et al. Surfactant-dependence of nanoparticle treatment in murine experimental colitis. J Control Release. 2013;172:62–68.
   PubMed Web of Science ®Google Scholar
• Xu L, Shen P, Bi Y, et al. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis. Int Immunopharmacol. 2016;38:385–394.
   PubMed Web of Science ®Google Scholar
• Wang X, Yang X, Wen C, et al. Grass carp TGF-β1 impairs IL-1β signaling in the inflammatory responses: evidence for the potential of TGF-β1 to antagonize inflammation in fish. Dev Comp Immunol. 2016;59:121–127.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhou Q, Dorfman RG, et al. Butyrate inhibits interleukin-17 and generates tregs to ameliorate colorectal colitis in rats. BMC Gastroenterol. 2016;16:84.
   PubMed Web of Science ®Google Scholar
• Zhu XM, Huang YM, Fan JF, et al. Aberrant frequency of IL-10-producing B cells and its association with the balance of Treg/Th17 in children with inflammatory bowel disease. Pharmazie. 2015;70:656–660.
   PubMed Web of Science ®Google Scholar
• Eastaff-Leung N, Mabarrack N, Barbour A, et al. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol. 2010;30:80–89.
   PubMed Web of Science ®Google Scholar
• Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010;129:311–321.
   PubMed Web of Science ®Google Scholar
• Park JS, Oh Y, Park O, et al. PEGylated TRAIL ameliorates experimental inflammatory arthritis by regulation of Th17 cells and regulatory T cells. J Control Release: *off J Control Release Soc. 2017;267:163–171.
   PubMed Web of Science ®Google Scholar
• Ma A, Yang Y, Wang Q, et al. Antiinflammatory effects of oxymatrine on rheumatoid arthritis in rats via regulating the imbalance between Treg and Th17 cells. Mol Med Rep. 2017;15:3615–3622.
   PubMed Web of Science ®Google Scholar
• Yuan X, Tong B, Dou Y, et al. Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor. Biochem Pharmacol. 2016;101:87–99.
   PubMed Web of Science ®Google Scholar